1 / 79

Post-transplant centrilobular hepatitis - rejection or autoimmune-like?

Post-transplant centrilobular hepatitis - rejection or autoimmune-like?. Andrew Clouston & Catherine Campbell Princess Alexandra Hospital, Australia University of Queensland, Australia. Outline. introduction pathology of CLH evolution possible pathogenesis. Centrilobular hepatitis.

fruma
Télécharger la présentation

Post-transplant centrilobular hepatitis - rejection or autoimmune-like?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Post-transplant centrilobular hepatitis- rejection or autoimmune-like? Andrew Clouston & Catherine Campbell Princess Alexandra Hospital, Australia University of Queensland, Australia

  2. Outline • introduction • pathology of CLH • evolution • possible pathogenesis

  3. Centrilobular hepatitis • Acute rejection • Chronic rejection • Vascular • Autoimmune hepatitis • “Central venulitis”

  4. Centrilobular hepatitis • Acute rejection portal changes • Chronic rejection duct changes • Vascular imaging • Autoimmune hepatitis histo & autoAb • “Central venulitis”

  5. Allo- vs Auto-immunity

  6. Allo- vs Auto-immunity

  7. Allo- vs Auto-immunity

  8. De novo AIH post-OLT • elevated transaminases • typical histology • interface hepatitis ++ • plasma cells

  9. De novo AIH post-OLT • elevated transaminases • typical histology • interface hepatitis ++ • plasma cells • late – median 24 months • autoantibodies • response to pred / aza

  10. 40 - 50% Salcedo Hepatology 2002

  11. CV CV

  12. Allo- vs Auto-immunity

  13. Late centrilobular hepatitis • Tsamandas 1997 • AR -- prognosis good • Nakazawa 2000 • hepatitis -- prognosis OK • Hassoon 2004 • AR (50%) – prognosis poor • >> evolution into CR IS THIS A FORM OF AR or AIH?

  14. Case • 28 yr old man previous farm worker • 1994 cryptogenic cirrhosis • March 2003 OLTx ; uneventful post op course

  15. Case • 28 yr old man previous farm worker • 1994 cryptogenic cirrhosis • March 2003 OLTx ; uneventful post op course • June 2004 abnormal LFTs • Transaminitis, BR normal • Immunosuppression stable • prednisolone 5mg, tacrolimus • Biopsy ?AR

  16. No treatment

  17. “Darrell”

  18. 2005 Draft statement on late liver allograft dysfunction (Banff working group) • “Central venulitis” • “Centrilobular inflammation +/- hepatocyte necrosis/dropout” • Peri-venular inflammation • Peri-venular hepatocyte necrosis/dropout • Haemorrhage • Pigmented macrophages

  19. Ddx “central venulitis” (Banff) • Acute rejection as isolated central venulitis • Perivenular inflammation with hepatocyte dropout and haemorrhage • Grading system provided • “severe” – damage of >3 hepatocyte layers in some central veins • Variable outcome

  20. ? Form of autoimmune- like hepatitis Hypothesis – centrilobular hepatitis ? Pure centrilobular form of AR

  21. Aims • Characterise “centrilobular hepatitis” • Nature of the histological changes • Associated clinical features • Document the natural history • Investigate possible mechanism

  22. Methods • Prospectively accrued cases from 1999 • Prominent“centrilobular hepatitis” on biopsy • No portal tract changes of AR or CR • Clinical details • baseline, biopsy and follow up LFTs • baseline immunosuppression • change in treatment • auto-antibody status

  23. Methods • Histological assessment

  24. CL portal

  25. Results • Seen in 24 pts (182 transplants) – 13% • 30 - 2850 days post-OLT • Mean 1066 days (~ 3 years) i.e. “late allograft dysfunction”

  26. Rejection n= 1 n=24 Moderate interface hepatitis & typical autoAb Autoimmune-like hepatitis Centrilobular hepatitis n=13 Original disease Recurrent AIH n=5 Denovo AI-like hepatitis n=5

  27. **

  28. **

  29. **

  30. **

  31. p=0.063

  32. ns

  33. *

  34. *p=0.051

  35. ns

  36. Histology - summary • Milder portal infiltrates • Milder interface hepatitis • Fewer portal plasma cells • Minimal duct injury PT

  37. Histology - summary • Milder portal infiltrates • Milder interface hepatitis • Fewer portal plasma cells • Minimal duct injury • Milder degree of CL dropout • Similar inflammatory infiltrate (↓ PC) • Overall lobular scores similar • Minimal endothelialitis PT Lob

More Related